Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Mclaughlin currently holds 30,001 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Mclaughlin has been a net seller of SNOA stock. They have purchased $0 and sold $156.2K worth of shares.
John Mclaughlin's most recent insider trade was on Jul 9, 2026, when they sold 10,000 shares at $0.00 per share.
John Mclaughlin serves as Executive at Sonoma Pharmaceuticals, Inc. (SNOA). They have executed 32 insider transactions totaling $156.2K over their tenure at the company.
John Mclaughlin holds the position of Executive at Sonoma Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
John Mclaughlin has shown a selling trading pattern, with $0 in total purchases and $156.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Mclaughlin was on Jun 29, 2007, when they sold $47.1K worth of CMPD.OB shares. This transaction involved 79,900 shares at $0.59 per share.
John Mclaughlin currently owns 30,001 shares of Sonoma Pharmaceuticals, Inc. (SNOA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Mclaughlin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Mclaughlin has 32 Form 4 filings on record as an insider at Sonoma Pharmaceuticals, Inc..
Set alerts for John Mclaughlin and 40,000+ other insiders.